STOCK TITAN
  1. Home
  2. Sec-filings
  3. QDEL
  4. [8-K] QuidelOrtho Corp Reports Material Event

QuidelOrtho (QDEL) CFO Joseph Busky to retire effective June 30, 2026

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

QuidelOrtho Corporation reported that its Chief Financial Officer and principal financial officer, Joseph M. Busky, has informed the company of his plans to retire, effective June 30, 2026. The company states that his decision is for personal reasons and not due to any disagreement regarding financial statements, operations, policies, or practices. This advance notice gives QuidelOrtho time to manage the transition in its senior financial leadership.

Positive

  • None.

Negative

  • None.

Insights

CFO plans retirement for personal reasons, with time for an orderly transition.

The announcement that QuidelOrtho's Chief Financial Officer, Joseph M. Busky, intends to retire effective June 30, 2026 signals an upcoming change in the company’s top financial leadership. The timing provides over four months’ lead time from the report date.

The company explicitly notes that the retirement is for personal reasons and not due to any disagreement over financial statements, operations, policies, or practices. That language is designed to limit concerns about underlying financial or control issues.

The long-dated effective retirement date allows QuidelOrtho to identify and integrate a successor before June 30, 2026. Future disclosures may outline the replacement CFO and any related adjustments to the finance organization.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

What did QuidelOrtho (QDEL) announce about its CFO in this 8-K?
QuidelOrtho announced that its Chief Financial Officer, Joseph M. Busky, plans to retire effective June 30, 2026. The filing describes this as a planned retirement for personal reasons, not tied to disagreements over financial reporting, operations, policies, or practices at the company.

When will QuidelOrtho (QDEL) CFO Joseph M. Busky retire?
Joseph M. Busky is expected to retire from his role as Chief Financial Officer and principal financial officer effective June 30, 2026. This effective date, disclosed in the 8-K, provides QuidelOrtho several months to manage succession and ensure continuity in its financial leadership.

Why is QuidelOrtho (QDEL) CFO Joseph M. Busky retiring?
The 8-K states that Joseph M. Busky’s decision to retire is for personal reasons. It further clarifies that his retirement is not the result of any disagreement with QuidelOrtho or its independent registered public accountants regarding financial statements, operations, policies, or practices.

What role does Joseph M. Busky hold at QuidelOrtho (QDEL) until retirement?
Joseph M. Busky serves as QuidelOrtho’s Chief Financial Officer and principal financial officer until his planned retirement on June 30, 2026. These roles place him in charge of the company’s top financial oversight and reporting functions during the transition period leading up to that date.

How much advance notice did QuidelOrtho (QDEL) give about the CFO retirement?
The 8-K reports that Joseph M. Busky notified QuidelOrtho of his retirement plans on February 9, 2026, with an effective date of June 30, 2026. This provides several months of advance notice, allowing time for planning and executing a succession process in the finance function.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
QuidelOrtho Corp false 0001906324 0001906324 2026-02-09 2026-02-09
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 9, 2026

 

 

QUIDELORTHO CORPORATION

(Exact name of Registrant as specified in its Charter)

 

 

 

Delaware   001-41409   87-4496285

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

9975 Summers Ridge Road, San Diego, California 92121

(Address of principal executive offices, including zip code)

(858) 552-1100

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.001 Par Value   QDEL   The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 9, 2026, Joseph M. Busky, the Chief Financial Officer and principal financial officer of QuidelOrtho Corporation (the “Company”), notified the Company of his plans to retire effective as of June 30, 2026. Mr. Busky’s decision to retire is for personal reasons and is not the result of any disagreement with the Company or its independent registered public accountants on any matter relating to the Company’s financial statements, operations, policies or practices.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 13, 2026

 

QUIDELORTHO CORPORATION
By:  

/s/ Michelle A. Hodges

Name:   Michelle A. Hodges
Its:   Secretary

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents